We utilized ptch1+/-/p53+/- double mutant mice for our studies because mutations in the p53 tumor suppressor gene in the context of ptch1 haploinsufficiency results in a higher incidence of MB than that in mice with the ptch1 mutation alone [38]. The gene discussed is TP53; the disease is neoplasm.